Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users

Clinical trial NCT06659029 · RECRUITING

Trial details

NCT number: NCT06659029
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Systemic Lupus Erythematosus

Start date: 2025-07-01
Primary completion: 2031-04-15
Enrollment: 442

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.